Overview

Because cell-mediated immunity declines with age, individuals aged 50 years and older are at increased risk for the reactivation of the latent varicella zoster virus that causes shingles. Immunocompromised and immunosuppressed individuals are at increased risk as well. Learn about vaccination recommendations to prevent shingles and complications of herpes zoster, especially postherpetic neuralgia.

Learning Objectives

  • Explain the risk factors, such as immunosenescence and immunodeficiency, that are associated with the development of herpes zoster
  • Identify complications of shingles and their impact on quality of life in affected individuals
  • Summarize the safety, efficacy, and dosing of the herpes zoster vaccine
  • Routinely recommend the herpes zoster vaccine to appropriate individuals, consistent with ACIP recommendations  
 

Courses

Faculty

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair 
Department of Geriatric and Palliative Medicine
Director, Comprehensive Care
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania

M. Susan Burke, MD, FACP

Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, Pennsylvania

Commercial Supporter

GlaxoSmithKline

Education Partner

Miller Medical Communications, LLC


Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.